Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group

被引：6

作者：

Raje, Noopur S. ^{[1
]}

Anaissie, Elias ^{[3
]}

Kumar, Shaji K. ^{[4
]}

Lonial, Sagar ^{[5
]}

Martin, Thomas ^{[6
]}

Gertz, Morie A. ^{[4
]}

Krishnan, Amrita ^{[7
]}

Hari, Parameswaran ^{[8
]}

Ludwig, Heinz ^{[9
]}

O'Donnell, Elizabeth ^{[1
]}

Yee, Andrew ^{[1
]}

Kaufman, Jonathan L. ^{[5
]}

Cohen, Adam D. ^{[10
]}

Garderet, Laurent ^{[11
]}

Wechalekar, Ashutosh F. ^{[13
]}

Terpos, Evangelos ^{[14
]}

Khatry, Navin ^{[15
,16
]}

Niesvizky, Ruben ^{[17
]}

Yi, Qing ^{[18
]}

Joshua, Douglas E. ^{[19
]}

Saikia, Tapan ^{[20
]}

Leung, Nelson ^{[4
]}

Engelhardt, Monika ^{[21
]}

Mothy, Mohamad ^{[12
]}

Branagan, Andrew ^{[1
]}

Chari, Ajai ^{[22
,23
]}

Reiman, Anthony J. ^{[24
]}

Lipe, Brea ^{[25
]}

Richter, Joshua ^{[22
,23
]}

Rajkumar, S. Vincent ^{[4
]}

San Miguel, Jesus ^{[26
]}

Anderson, Kenneth C. ^{[2
]}

Stadtmauer, Edward A. ^{[10
]}

Prabhala, Rao H. ^{[2
]}

McCarthy, Phillip L. ^{[27
]}

Munshi, Nikhil C. ^{[2
]}

机构：

[1] Harvard Med Sch, Ctr Multiple Myeloma, Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA

[2] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02114 USA

[3] CTI Clin Trial & Consulting Serv, Cincinnati, OH USA

[4] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA

[5] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA USA

[6] Univ Calif San Francisco, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[7] City Hope Natl Med Ctr, Judy & Bernard Briskin Myeloma Ctr, Duarte, CA USA

[8] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA

[9] Clin Ottakring, Wilhelminen Canc Res Inst, Dept Med 1, Vienna, Austria

[10] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[11] Hop St Antoine, AP HP, Serv Hematol & Therapie Cellulaire, Paris, France

[12] Hop St Antoine, AP HP, Hematol Dept, Paris, France

[13] UCL, Natl Amyloidosis Ctr, London, England

[14] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Athens, Greece

[15] Tata Mem Hosp, Dept Med Oncol, Mumbai, Maharashtra, India

[16] Homi Bhabha Natl Inst, Mumbai, Maharashtra, India

[17] Weill Cornell Med, Div Hematol & Oncol, New York, NY USA

[18] Houston Methodist Res Inst, Canc Ctr Basic Res Programs, Houston, TX USA

[19] Royal Prince Alfred Hosp, Inst Haematol, NSW Hlth Pathol, Camperdown, NSW, Australia

[20] Prince Aly Khan Hosp, Bone Marrow Transplantat & Med Oncol Dept, Mumbai, Maharashtra, India

[21] Univ Freiburg, Fac Med, Med Ctr, Freiburg, Germany

[22] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA

[23] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA

[24] St Johns Hosp, Dept Oncol, St John, NB, Canada

[25] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA

[26] Clin Univ Navarra, Ctr Invest Med Aplicada, Inst Invest Sanitaria Navarra, Pamplona, Spain

[27] Roswell Park Comprehens Canc Ctr, Dept Med, Buffalo, NY USA

来源：

LANCET HAEMATOLOGY | 2022年 / 9卷 / 02期

关键词：

STEM-CELL TRANSPLANTATION; PNEUMOCYSTIS-JIROVECII PNEUMONIA; BONE-MARROW-TRANSPLANTATION; HEPATITIS-C VIRUS; INTRAVENOUS IMMUNOGLOBULIN; HEMATOLOGICAL MALIGNANCIES; STREPTOCOCCUS-PNEUMONIAE; MONOCLONAL GAMMOPATHY; EARLY MORTALITY; AUTOLOGOUS TRANSPLANTATION;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Infection remains the leading cause of morbidity and mortality in patients with multiple myeloma because of the cumulative effect of disease, treatment, and host-related factors. Given that infectious risk is cumulative through the course of the disease, preventing infections is paramount. Optimal preventive strategies include vaccination against common pathogens, antimicrobial prophylaxis, infection control measures, and immunoglobulin replacement in a small subset of patients; however, there are no universally accepted guidelines for infection prevention. This Review provides a consensus statement from a panel of 36 experts with global representation, which was convened by The International Myeloma Society to review existing literature and current guidelines, address issues associated with the risk of infection and prevention of infectious complications in multiple myeloma in the context of emerging therapies, and offer recommendations for preventing these complications.

引用

页码：E143 / E161

页数：19

共 50 条

[1] Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
Laubach, J.
Garderet, L.
Mahindra, A.
Gahrton, G.
Caers, J.
Sezer, O.
Voorhees, P.
Leleu, X.
Johnsen, H. E.
Streetly, M.
Jurczyszyn, A.
Ludwig, H.
Mellqvist, U-H
Chng, W-J
Pilarski, L.
Einsele, H.
Hou, J.
Turesson, I.
Zamagni, E.
Chim, C. S.
Mazumder, A.
Westin, J.
Lu, J.
Reiman, T.
Kristinsson, S.
Joshua, D.
Roussel, M.
O'Gorman, P.
Terpos, E.
McCarthy, P.
Dimopoulos, M.
Moreau, P.
Orlowski, R. Z.
Miguel, J. S.
Anderson, K. C.
Palumbo, A.
Kumar, S.
Rajkumar, V.
Durie, B.
Richardson, P. G.
LEUKEMIA, 2016, 30 (05) : 1005 - 1017
[2] Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
J Laubach
L Garderet
A Mahindra
G Gahrton
J Caers
O Sezer
P Voorhees
X Leleu
H E Johnsen
M Streetly
A Jurczyszyn
H Ludwig
U-H Mellqvist
W-J Chng
L Pilarski
H Einsele
J Hou
I Turesson
E Zamagni
C S Chim
A Mazumder
J Westin
J Lu
T Reiman
S Kristinsson
D Joshua
M Roussel
P O'Gorman
E Terpos
P McCarthy
M Dimopoulos
P Moreau
R Z Orlowski
J S Miguel
K C Anderson
A Palumbo
S Kumar
V Rajkumar
B Durie
P G Richardson
Leukemia, 2016, 30 : 1005 - 1017
[3] Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Moreau, Philippe
Kumar, Shaji K.
Miguel, Jesus San
Davies, Faith
Zamagni, Elena
Bahlis, Nizar
Ludwig, Heinz
Mikhael, Joseph
Terpos, Evangelos
Schjesvold, Fredrik
Martin, Thomas
Yong, Kwee
Durie, Brian G. M.
Facon, Thierry
Jurczyszyn, Artur
Sidana, Surbhi
Raje, Noopur
Donk, Niels van de
Lonial, Sagar
Cavo, Michele
Kristinsson, Sigurdur Y.
Lentzsch, Suzanne
Hajek, Roman
Anderson, Kenneth C.
Joao, Cristina
Einsele, Hermann
Sonneveld, Pieter
Engelhardt, Monika
Fonseca, Rafael
Vangsted, Annette
Weisel, Katja
Baz, Rachid
Hungria, Vania
Berdeja, Jesus G.
da Costa, Fernando Leal
Maiolino, Angelo
Waage, Anders
Vesole, David H.
Ocio, Enrique M.
Quach, Hang
Driessen, Christoph
Blade, Joan
Leleu, Xavier
Riva, Eloisa
Bergsagel, Peter Leif
Hou, Jian
Chng, Wee Joo
Mellqvist, Ulf-Henrik
Dytfeld, Dominik
Harousseau, Jean-Luc
LANCET ONCOLOGY, 2021, 22 (03): : E105 - E118
[4] Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
Palumbo, Antonio
Avet-Loiseau, Herve
Oliva, Stefania
Lokhorst, Henk M.
Goldschmidt, Hartmut
Rosinol, Laura
Richardson, Paul
Caltagirone, Simona
Jose Lahuerta, Juan
Facon, Thierry
Bringhen, Sara
Gay, Francesca
Attal, Michel
Passera, Roberto
Spencer, Andrew
Offidani, Massimo
Kumar, Shaji
Musto, Pellegrino
Lonial, Sagar
Petrucci, Maria T.
Orlowski, Robert Z.
Zamagni, Elena
Morgan, Gareth
Dimopoulos, Meletios A.
Durie, Brian G. M.
Anderson, Kenneth C.
Sonneveld, Pieter
San Miguel, Jesus
Cavo, Michele
Rajkumar, S. Vincent
Moreau, Philippe
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2863 - +
[5] Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group
Terpos, Evangelos
Zamagni, Elena
Lentzsch, Suzanne
Drake, Matthew T.
Garcia-Sanz, Ramon
Abildgaard, Niels
Ntanasis-Stathopoulos, Ioannis
Schjesvold, Fredrik
de la Rubia, Javier
Kyriakou, Charalampia
Hillengass, Jens
Zweegman, Sonja
Cavo, Michele
Moreau, Philippe
San-Miguel, Jesus
Dimopoulos, Meletios A.
Munshi, Nikhil
Durie, Brian G. M.
Raje, Noopur
LANCET ONCOLOGY, 2021, 22 (03): : E119 - E130
[6] The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group consensus statement
Hussein, M. A.
Vrionis, F. D.
Allison, R.
Berenson, J.
Berven, S.
Erdem, E.
Giralt, S.
Jagannath, S.
Kyle, R. A.
LeGrand, S.
Pflugmacher, R.
Raje, N.
Rajkumar, S. V.
Randall, R. L.
Roodman, D.
Siegel, D.
Vescio, R.
Zonder, J.
Durie, B. G. M.
LEUKEMIA, 2008, 22 (08) : 1479 - 1484
[7] The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
M A Hussein
F D Vrionis
R Allison
J Berenson
S Berven
E Erdem
S Giralt
S Jagannath
R A Kyle
S LeGrand
R Pflugmacher
N Raje
S V Rajkumar
L Randall
D Roodman
D Siegel
R Vescio
J Zonder
B G M Durie
Leukemia, 2008, 22 : 1479 - 1484
[8] Treatment of the multiple myeloma with high cytogenetic risk: a consensus of the International Myeloma Working Group
Machet, Antoine
Cayssials, Emilie
Guidez, Stephanie
Leleu, Xavier
HEMATOLOGIE, 2016, 22 (04): : 250 - +
[9] Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Munshi, Nikhil C.
Anderson, Kenneth C.
Bergsagel, P. Leif
Shaughnessy, John
Palumbo, Antonio
Durie, Brian
Fonseca, Rafael
Stewart, A. Keith
Harousseau, Jean-Luc
Dimopoulos, Meletios
Jagannath, Sundar
Hajek, Roman
Sezer, Orhan
Kyle, Robert
Sonneveld, Pieter
Cavo, Michele
Rajkumar, S. Vincent
San Miguel, Jesus
Crowley, John
Avet-Loiseau, Herve
BLOOD, 2011, 117 (18) : 4696 - 4700
[10] International Myeloma Working Group recommendations for global myeloma care
Ludwig, H.
Miguel, J. S.
Dimopoulos, M. A.
Palumbo, A.
Garcia Sanz, R.
Powles, R.
Lentzsch, S.
Chen, W. Ming
Hou, J.
Jurczyszyn, A.
Romeril, K.
Hajek, R.
Terpos, E.
Shimizu, K.
Joshua, D.
Hungria, V.
Rodriguez Morales, A.
Ben-Yehuda, D.
Sondergeld, P.
Zamagni, E.
Durie, B.
LEUKEMIA, 2014, 28 (05) : 981 - 992

← 1 2 3 4 5 →